BDBM66229 2-[2-(4-Amino-furazan-3-yl)-benzoimidazol-1-yl]-N-cyclopentyl-acetamide::2-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-benzimidazolyl]-N-cyclopentylacetamide::2-[2-(4-amino-1,2,5-oxadiazol-3-yl)benzimidazol-1-yl]-N-cyclopentylacetamide::2-[2-(4-aminofurazan-3-yl)benzimidazol-1-yl]-N-cyclopentyl-acetamide::2-[2-(4-azanyl-1,2,5-oxadiazol-3-yl)benzimidazol-1-yl]-N-cyclopentyl-ethanamide::MLS000034179::SMR000013415::cid_647609

SMILES Nc1nonc1-c1nc2ccccc2n1CC(=O)NC1CCCC1

InChI Key InChIKey=PMSOMNNQJZCLEV-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 66229   

TargetBcl-2-like protein 11(Human)
Broad Institute

Curated by PubChem BioAssay
LigandPNGBDBM66229(2-[2-(4-azanyl-1,2,5-oxadiazol-3-yl)benzimidazol-1...)
Affinity DataEC50: >3.50E+5nMAssay Description:Keywords: apoptosis, BH3 domain, Bcl2-A1, BIM, caspase, cancer Primary Collaborator: Todd Golub, Broad Institute, golub@broadinstitute.org Assay Over...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2011
Entry Details
PCBioAssay